Analyst Ratings for Mateon Therapeutics (MATN)

MATN Rating Summary

MATN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MATN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $3.00 (+1053.8%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/7/2020 Litchfield Hills Research Theodore O'Neill New Coverage Buy
(N/A)
3.00
(N/A)
0.20
(0.26)
30% Details
8/17/2018 H.C. Wainwright Joseph Pantginis Downgrade Neutral
(Buy)
N/A
(N/A)
0.14
(0.26)
85.71% Details
Like MATN Ratings? Also take a look at IQV

MATN Ratings News